We are live on
!
Find out more
Ken Fisher Fisher Asset Management
AUM
$295B
1-Year Est. Return
32.61%
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
This Fund
S&P 500
1 Year Est. Return
+32.61%
AUM
$295B
AUM Growth
+$1.9B
(+0.65%)
Holding
1,133
Top Buys
| 1 | +$1.88B | |
| 2 | +$1.41B | |
| 3 | +$1.17B | |
| 4 |
Cisco
CSCO
|
+$1.1B |
| 5 |
Novartis
NVS
|
+$984M |
Top Sells
| 1 | +$1.74B | |
| 2 | +$1.21B | |
| 3 | +$1.06B | |
| 4 |
Stryker
SYK
|
+$955M |
| 5 |
Boston Scientific
BSX
|
+$695M |
Sector Composition
| 1 | Technology | 23.16% |
| 2 | Financials | 17.3% |
| 3 | Industrials | 10.45% |
| 4 | Healthcare | 9.91% |
| 5 | Energy | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Trustmark
TRMK
$2.65B
| $15.6M | 0.01% |
370,509
-754
|
|
||
352
Pinnacle Financial Partners Inc
PNFP
$14.5B
| $14.9M | 0.01% |
+173,476
|
|
||
353
WSFS Financial
WSFS
$3.86B
| $14.9M | 0.01% |
227,911
-35
|
|
||
354
Prestige Consumer Healthcare
PBH
$2.21B
| $14.9M | 0.01% |
251,165
-22,720
|
|
||
355
Avient
AVNT
$3.44B
| $14.9M | 0.01% |
409,583
-3,066
|
|
||
356
Tanger
SKT
$4.67B
| $14.3M | ﹤0.01% |
421,486
-38,456
|
|
||
357
LXP Industrial Trust
LXP
$3.19B
| $14.3M | ﹤0.01% |
308,397
-490
|
|
||
358
Zscaler
ZS
$20.6B
| $14.3M | ﹤0.01% |
101,657
-1,311
|
|
||
359
Box
BOX
$3.53B
| $14M | ﹤0.01% |
593,865
-13,273
|
|
||
360
Vertex Pharmaceuticals
VRTX
$114B
| $13.9M | ﹤0.01% |
31,158
+5,940
|
|
||
361
Chord Energy
CHRD
$7.18B
| $13.9M | ﹤0.01% |
97,775
+14,493
|
|
||
362
Alkermes
ALKS
$7.35B
| $13.8M | ﹤0.01% |
390,479
-14
|
|
||
363
First Merchants
FRME
$2.59B
| $13.5M | ﹤0.01% |
348,861
-26,415
|
|
||
364
Ameris Bancorp
ABCB
$5.91B
| $13.4M | ﹤0.01% |
172,000
-19,110
|
|
||
365
Constellium
CSTM
$4.73B
| $13.3M | ﹤0.01% |
539,451
+529,278
|
|
||
366
Tesla
TSLA
$1.52T
| $12.9M | ﹤0.01% |
34,755
-441
|
|
||
367
Atlantic Union Bankshares
AUB
$5.66B
| $12.9M | ﹤0.01% |
360,253
-38
|
|
||
368
Warner Bros
WBD
$66.7B
| $12.9M | ﹤0.01% |
468,145
-44,083
|
|
||
369
Credicorp
BAP
$28.8B
| $12.7M | ﹤0.01% |
37,378
-13,738
|
|
||
370
Urban Edge Properties
UE
$2.89B
| $12.7M | ﹤0.01% |
633,243
-23,251
|
|
||
371
Commault Systems
CVLT
$5.25B
| $12.6M | ﹤0.01% |
162,348
-16
|
|
||
372
Viavi Solutions
VIAV
$12.4B
| $12.6M | ﹤0.01% |
379,600
-63,696
|
|
||
373
Domino's
DPZ
$10.5B
| $12.4M | ﹤0.01% |
34,481
-151
|
|
||
374
Core Laboratories
CLB
$586M
| $12.4M | ﹤0.01% |
736,747
-38,232
|
|
||
375
Bristol-Myers Squibb
BMY
$115B
| $12.4M | ﹤0.01% |
203,654
-1,074
|
|